Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC)

Clinical trial NCT02955602 · COMPLETED

Trial details

NCT number: NCT02955602
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Biliary Cirrhosis

Start date: 2016-11-28
Primary completion: 2018-09-07
Enrollment: 119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.